Phase II Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin (cSCC)
A091802 Registration (Step 1) is closed to accrual, effective September 29, 2023.
A091802 Pre-registration (Step 0) is closed to accrual, effective August 29, 2023.
